我院与中国科学院微生物所复合核苷小组及首都啤酒厂协作,由该两单位制作和提供复合核苷注射液,自1971年2月起使用此药治疗急、慢性肝炎以及肝硬变共70例,初步得到一定疗效。对其中有效组的一部分患者33例追访至1972年10月,以观察其远期疗效和巩固的情况。 Our institute cooperated with the compound nucleosides group of Institute of Microbiology and the Capital Brewery Company of Chinese Academy of Sciences to produce and provide the compound nucleoside injection solution. Since February 1971, this medicine has been used in the treatment of acute, chronic hepatitis and cirrhosis For example, initially get a certain effect. A group of 33 patients who were part of the effective group were followed up until October 1972 to observe their long-term efficacy and consolidation.